Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Infliximab for the treatment of plaque psoriasisBiologics, 2008-03, Vol.2 (1), p.115-124 [Peer Reviewed Journal]2008. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2008 Dove Medical Press Limited. All rights reserved ;ISSN: 1177-5475 ;ISSN: 1177-5491 ;EISSN: 1177-5491 ;DOI: 10.2147/BTT.S2116 ;PMID: 19707434Full text available |
|
2 |
Material Type: Article
|
Principal long-term adverse effects of imatinib in patients with chronic myeloid leukemia in chronic phaseBiologics, 2010-01, Vol.4, p.315-323 [Peer Reviewed Journal]2010. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2010 Mughal and Schrieber, publisher and licensee Dove Medical Press Ltd. ;ISSN: 1177-5475 ;ISSN: 1177-5491 ;EISSN: 1177-5491 ;DOI: 10.2147/btt.s5775 ;PMID: 21209726Full text available |
|
3 |
Material Type: Article
|
Multikinase inhibitors use in differentiated thyroid carcinomaBiologics, 2014-01, Vol.8 (default), p.281-291 [Peer Reviewed Journal]2014. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2014 Jasim et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License 2014 ;ISSN: 1177-5475 ;ISSN: 1177-5491 ;EISSN: 1177-5491 ;DOI: 10.2147/BTT.S57619 ;PMID: 25506209Full text available |
|
4 |
Material Type: Article
|
Emerging hematological targets and therapy for cardiovascular disease : from bench to bedsideBiologics, 2008-09, Vol.2 (3), p.397-407 [Peer Reviewed Journal]2008. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2008 Villegas et al, publisher and licensee Dove Medical Press Ltd. This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited. ;ISSN: 1177-5475 ;ISSN: 1177-5491 ;EISSN: 1177-5491 ;DOI: 10.2147/BTT.S2911 ;PMID: 19707371Full text available |
|
5 |
Material Type: Article
|
Biological drugs targeting the immune response in the therapy of psoriasisBiologics, 2008-12, Vol.2 (4), p.687-697 [Peer Reviewed Journal]2008. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2008 Pastore et al, publisher and licensee Dove Medical Press Ltd. This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited. ;ISSN: 1177-5475 ;ISSN: 1177-5491 ;EISSN: 1177-5491 ;DOI: 10.2147/BTT.S2763 ;PMID: 19707449Full text available |
|
6 |
Material Type: Article
|
Long term efficacy and safety of etanercept in the treatment of psoriasis and psoriatic arthritisBiologics, 2014-01, Vol.8 (default), p.169-182 [Peer Reviewed Journal]COPYRIGHT 2014 Dove Medical Press Limited ;2014. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2014 Kivelevitch et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License 2014 ;ISSN: 1177-5475 ;ISSN: 1177-5491 ;EISSN: 1177-5491 ;DOI: 10.2147/BTT.S41481 ;PMID: 24790410Full text available |
|
7 |
Material Type: Article
|
Optimizing therapeutics in the management of patients with multiple sclerosis : a review of drug efficacy, dosing, and mechanisms of actionBiologics, 2013-01, Vol.7 (default), p.247-258 [Peer Reviewed Journal]COPYRIGHT 2013 Dove Medical Press Limited ;2013. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2013 Damal et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License 2013 ;ISSN: 1177-5475 ;ISSN: 1177-5491 ;EISSN: 1177-5491 ;DOI: 10.2147/BTT.S53007 ;PMID: 24324326Full text available |
|
8 |
Material Type: Article
|
Bevacizumab in the treatment of HER2-negative breast cancerBiologics, 2008-01, Vol.2 (4), p.813-821 [Peer Reviewed Journal]2008. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2008 Dove Medical Press Limited. All rights reserved ;ISSN: 1177-5475 ;ISSN: 1177-5491 ;EISSN: 1177-5491 ;DOI: 10.2147/btt.s3515 ;PMID: 19707460Full text available |
|
9 |
Material Type: Article
|
Current neoadjuvant treatment options for HER2 positive breast cancerBiologics, 2011-01, Vol.5 (default), p.87-94 [Peer Reviewed Journal]2011. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2011 Abdel-Razeq and Marei, publisher and licensee Dove Medical Press Ltd. 2011 ;ISSN: 1177-5475 ;ISSN: 1177-5491 ;EISSN: 1177-5491 ;DOI: 10.2147/BTT.S22917 ;PMID: 21847344Full text available |
|
10 |
Material Type: Article
|
Resistant mutations in CML and Ph+ALL - role of ponatinibBiologics, 2014-01, Vol.8 (default), p.243-253 [Peer Reviewed Journal]2014. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2014 Miller et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License 2014 ;ISSN: 1177-5475 ;ISSN: 1177-5491 ;EISSN: 1177-5491 ;DOI: 10.2147/BTT.S50734 ;PMID: 25349473Full text available |
|
11 |
Material Type: Article
|
Drug focus : adalimumab in the treatment of moderate to severe psoriasisBiologics, 2007-06, Vol.1 (2), p.93-103 [Peer Reviewed Journal]Copyright Taylor & Francis Ltd. 2007 ;2007 Dove Medical Press Limited. All rights reserved ;ISSN: 1177-5475 ;ISSN: 1177-5491 ;EISSN: 1177-5491 ;PMID: 19707319Full text available |
|
12 |
Material Type: Article
|
Adalimumab for the treatment of Crohn's diseaseBiologics, 2008-01, Vol.2 (4), p.763-777 [Peer Reviewed Journal]2008. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2008 Dove Medical Press Limited. All rights reserved ;ISSN: 1177-5475 ;ISSN: 1177-5491 ;EISSN: 1177-5491 ;DOI: 10.2147/BTT.S3292 ;PMID: 19707457Full text available |
|
13 |
Material Type: Article
|
HER2 breast cancer therapies : a reviewBiologics, 2009-01, Vol.3 (default), p.289-301 [Peer Reviewed Journal]2009. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2009 Murphy and Modi, publisher and licensee Dove Medical Press Ltd ;ISSN: 1177-5475 ;ISSN: 1177-5491 ;EISSN: 1177-5491 ;DOI: 10.2147/BTT.S3479 ;PMID: 19707416Full text available |
|
14 |
Material Type: Article
|
Effect of mild aerobic training on the myocardium of mice with chronic Chagas diseaseBiologics, 2015-01, Vol.9 (default), p.87-92 [Peer Reviewed Journal]COPYRIGHT 2015 Dove Medical Press Limited ;2015. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2015 Preto et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License 2015 ;ISSN: 1177-5475 ;ISSN: 1177-5491 ;EISSN: 1177-5491 ;DOI: 10.2147/BTT.S85283 ;PMID: 26445527Full text available |
|
15 |
Material Type: Article
|
Epoetin zeta in the management of anemia associated with chronic kidney disease, differential pharmacology and clinical utilityBiologics, 2014-01, Vol.8 (default), p.155-167 [Peer Reviewed Journal]COPYRIGHT 2014 Dove Medical Press Limited ;2014. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2014 Davis-Ajami et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License 2014 ;ISSN: 1177-5475 ;ISSN: 1177-5491 ;EISSN: 1177-5491 ;DOI: 10.2147/BTT.S27578 ;PMID: 24790409Full text available |
|
16 |
Material Type: Article
|
Review of palivizumab in the prophylaxis of respiratory syncytial virus (RSV) in high-risk infantsBiologics, 2008-09, Vol.2 (3), p.433-439 [Peer Reviewed Journal]2008. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2008 Dove Medical Press Limited. All rights reserved ;ISSN: 1177-5475 ;ISSN: 1177-5491 ;EISSN: 1177-5491 ;DOI: 10.2147/btt.s3104 ;PMID: 19707374Full text available |
|
17 |
Material Type: Article
|
Safety of biologics in rheumatoid arthritis : data from randomized controlled trials and registriesBiologics, 2015-01, Vol.9 (default), p.1-6 [Peer Reviewed Journal]COPYRIGHT 2015 Dove Medical Press Limited ;2015. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2015 Codreanu and Damjanov. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License 2015 ;ISSN: 1177-5475 ;ISSN: 1177-5491 ;EISSN: 1177-5491 ;DOI: 10.2147/BTT.S68949 ;PMID: 25670881Full text available |
|
18 |
Material Type: Article
|
Describing the hexapeptide identity platform between the influenza A H5N1 and Homo sapiens proteomesBiologics, 2010-09, Vol.4 (default), p.245-261, Article 245 [Peer Reviewed Journal]2010. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2010 Kanduc, publisher and licensee Dove Medical Press Ltd. ;ISSN: 1177-5475 ;ISSN: 1177-5491 ;EISSN: 1177-5491 ;DOI: 10.2147/BTT.S12097 ;PMID: 20859452Full text available |
|
19 |
Material Type: Article
|
Clinical use of crizotinib for the treatment of non-small cell lung cancerBiologics, 2013-01, Vol.7 (default), p.91-101 [Peer Reviewed Journal]2013. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2013 Roberts, publisher and licensee Dove Medical Press Ltd 2013 ;ISSN: 1177-5475 ;ISSN: 1177-5491 ;EISSN: 1177-5491 ;DOI: 10.2147/BTT.S29026 ;PMID: 23671386Full text available |
|
20 |
Material Type: Article
|
Pharmacoutilization of epoetins in naïve patients with hematological malignancies in an unselected Italian population under clinical practice setting : a comparative analysis between originator and biosimilarsBiologics, 2016-12, Vol.10, p.157-165 [Peer Reviewed Journal]COPYRIGHT 2016 Dove Medical Press Limited ;2016 Perrone et al. This work is published and licensed by Dove Medical Press Limited 2016 ;ISSN: 1177-5491 ;ISSN: 1177-5475 ;EISSN: 1177-5491 ;DOI: 10.2147/BTT.S114625 ;PMID: 27942203Full text available |